A Study of 14C-Bleximenib (Radiolabeled) in Participants With Acute Leukemia
Abroad (travel likely)RecruitingPHASE1
Conditions
Acute Lymphoblastic Leukemia · Acute Leukemias · Acute Myeloid Leukemia
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
The Christie NHS Foundation Trust Christie Hospital, Manchester, United Kingdom
Study leads
Janssen Research & Development, LLC Clinical Trial
Study Director
Janssen Research & Development, LLC